Skip to main content
. Author manuscript; available in PMC: 2014 Feb 6.
Published in final edited form as: Leuk Lymphoma. 2013 Mar 4;54(10):2163–2167. doi: 10.3109/10428194.2013.767901

Table III.

Change in stage based on FDG-PET.

Stage change Reason
Upstage
1. Stage I → III Axillary, inguinal lymph nodes detected
2. Stage II → IV Nasopharynx, tonsil lesions detected
Downstage
1. Stage IV → III Lung lesions not detected by FDG-PET
2. Stage IV → III Lung lesions not detected by FDG-PET
3. Stage III → 0 No FDG uptake in neoplastic lesions

FDG-PET, 18F-fluorodeoxyglucose positron emission tomography.